Gender-affirming hormone therapy may increase risk of high blood pressure
Scienmag
APRIL 19, 2021
Hypertension Journal report DALLAS, April 19, 2021 — Gender-affirming hormone therapy (GAHT) was associated with blood pressure changes in both transgender men and women, according to new research published today in Hypertension, an American Heart Association journal.
Let's personalize your content